Reporter: Ann Komis
Web Producer: Kerry Corum
Five to ten million Americans suffer from Fibromyalgia.
It's a condition characterized by extreme pain and muscle stiffness. It's often treated with anti-depressants.
Now, newer more targeted therapies may soon be available.
For more than 20 years, Elizabeth Tross-Deamer suffered the pain of Fibromyalgia.
She started taking a new medication called Pregabalin, and her pain subsided.
She says, "The memory is better. My relationships are better. People like me a lot more."
For the first time in years, this wine author can sleep at night, giving her back energy and stamina during the day.
Bernadine Smith took a different drug called Milnacipran, and had similar results. She says, "I didn't have as much depression. I wasn't as fatigued."
Dr. Philip Mease is testing both drugs, in separate studies. He says, "At least a third of the patients in both trials, have experienced, roughly, a 50-percent reduction in pain."
The drugs come from different families, Pregabalin is a pain reliever, Milnacipran an anti-depressant.
Dr Mease says,"What both of these medications are doing, are restoring to a more natural balance the neuro-chemicals in the brain that are off kilter, in this condition."
Both drugs are still in trials, but for these two women, the verdict is already in.